↓ Skip to main content

Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation

Overview of attention for article published in Cardiovascular Drugs and Therapy, September 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
70 Mendeley
Title
Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation
Published in
Cardiovascular Drugs and Therapy, September 2019
DOI 10.1007/s10557-019-06907-8
Pubmed ID
Authors

Ralf E. Harskamp, Martina Teichert, Wim A. M. Lucassen, Henk C. P. M. van Weert, Renato D. Lopes

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 14%
Student > Postgraduate 8 11%
Student > Master 8 11%
Student > Ph. D. Student 6 9%
Student > Bachelor 5 7%
Other 11 16%
Unknown 22 31%
Readers by discipline Count As %
Medicine and Dentistry 23 33%
Pharmacology, Toxicology and Pharmaceutical Science 14 20%
Nursing and Health Professions 2 3%
Computer Science 1 1%
Biochemistry, Genetics and Molecular Biology 1 1%
Other 2 3%
Unknown 27 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2022.
All research outputs
#14,264,928
of 22,875,477 outputs
Outputs from Cardiovascular Drugs and Therapy
#435
of 686 outputs
Outputs of similar age
#186,654
of 339,549 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#7
of 7 outputs
Altmetric has tracked 22,875,477 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 686 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,549 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.